Neurokine Pharmaceuticals Inc Share Price Other OTC
Equities
CAC611561100
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
04-03 | BetterLife Pharma Inc. announced that it has received CAD 1.168 million in funding | CI |
03-04 | BetterLife Pharma Inc. announced that it expects to receive CAD 0.1 million in funding | CI |
Sales 2022 | - | Sales 2023 | - | Capitalization | 13.32M 1.07B |
---|---|---|---|---|---|
Net income 2022 | -12M -962M | Net income 2023 | -9M -722M | EV / Sales 2022 | - |
Net Debt 2022 | 139K 11.14M | Net Debt 2023 | 71.69K 5.75M | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.26
x | P/E ratio 2023 |
-1.36
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 77.36% |
Managers | Title | Age | Since |
---|---|---|---|
Ahmad Doroudian
CEO | Chief Executive Officer | 63 | 16/09/07 |
Moira Ong
DFI | Director of Finance/CFO | 49 | 25/12/10 |
Chief Operating Officer | 67 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Ahmad Doroudian
CEO | Chief Executive Officer | 63 | 16/09/07 |
Robert Metcalfe
BRD | Director/Board Member | 84 | 20/01/20 |
Wolfgang Renz
BRD | Director/Board Member | 54 | 04/02/15 |
1st Jan change | Capi. | |
---|---|---|
-3.46% | 102B | |
+1.41% | 96.09B | |
+2.13% | 22.28B | |
-15.84% | 21.4B | |
-9.37% | 18.14B | |
-39.98% | 17.02B | |
-14.65% | 16.09B | |
+4.39% | 13.83B | |
+31.35% | 11.97B |